The European Commission wants to change legislation for biotechnology. Many in civil society fear an all-out deregulation agenda. ‘We have not announced a deregulation of new genomic techniques,’ the Commission rebuts. ‘But we would look at suitable regulatory oversight with very limited scope.’  Hans Wetzels presents an overview of developments in the regulation of new genomic techniques.  […]